81 FR 492 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 81, Issue 3 (January 6, 2016)

Page Range		492-492
FR Document		2015-33256

Federal Register, Volume 81 Issue 3 (Wednesday, January 6, 2016)

[Federal Register Volume 81, Number 3 (Wednesday, January 6, 2016)]
[Notices]
[Page 492]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2015-33256]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Neurological Disorders and Stroke; Notice 
of Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Neurological Disorders 
and Stroke Special Emphasis Panel; X01's BRAC Review.
    Date: January 14, 2016.
    Time: 1:00 p.m. to 2:30 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, Neuroscience Center, 6001 
Executive Boulevard, Rockville, MD 20852 (Telephone Conference 
Call).
    Contact Person: Joel A. Saydoff, Ph.D., Scientific Review 
Officer, Scientific Review Branch, Division of Extramural Research, 
NINDS/NIH/DHHS/Neuroscience Center, 6001 Executive Boulevard, Suite 
3205, MSC 9529, Bethesda, MD 20892-9529, 301-435-9223, 
[email protected].

    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

(Catalogue of Federal Domestic Assistance Program Nos. 93.853, 
Clinical Research Related to Neurological Disorders; 93.854, 
Biological Basis Research in the Neurosciences, National Institutes 
of Health, HHS)

    Dated: December 31, 2015.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-33256 Filed 1-5-16; 8:45 am]
BILLING CODE 4140-01-P

492 Federal Register / Vol. 81, No. 3 / Wednesday, January 6, 2016 / Notices

limited. If the number of registrants Date: January 14, 2016. Contact Person: Gerald L. McLaughlin,
requesting to speak is greater than can Time: 1:00 p.m. to 2:30 p.m. Ph.D., Scientific Review Officer, Office of
be reasonably accommodated during the Agenda: To review and evaluate grant Extramural Policy and Review, National
applications. Institute on Drug Abuse, NIH, DHHS, 6001
scheduled open public hearing session,
Place: National Institutes of Health, Executive Blvd., Room 4238, MSC 9550,
FDA may conduct a lottery to determine Neuroscience Center, 6001 Executive Bethesda, MD 20892–9550, 301–402–6626,
the speakers for the scheduled open Boulevard, Rockville, MD 20852 (Telephone gm145a@nih.gov.
public hearing session. The contact Conference Call). (Catalogue of Federal Domestic Assistance
person will notify interested persons Contact Person: Joel A. Saydoff, Ph.D., Program No.: 93.279, Drug Abuse and
regarding their request to speak by Scientific Review Officer, Scientific Review Addiction Research Programs, National
February 11, 2016. Branch, Division of Extramural Research, Institutes of Health, HHS)
Persons attending FDA’s advisory NINDS/NIH/DHHS/Neuroscience Center,
committee meetings are advised that the 6001 Executive Boulevard, Suite 3205, MSC Dated: December 31, 2015.
Agency is not responsible for providing 9529, Bethesda, MD 20892–9529, 301–435– Natasha M. Copeland,
9223, joel.saydoff@nih.gov.
access to electrical outlets. Program Analyst, Office of Federal Advisory
FDA welcomes the attendance of the This notice is being published less than 15 Committee Policy.
public at its advisory committee days prior to the meeting due to the timing [FR Doc. 2015–33252 Filed 1–5–16; 8:45 am]
meetings and will make every effort to limitations imposed by the review and
BILLING CODE 4140–01–P
accommodate persons with disabilities. funding cycle.
If you require accommodations due to a (Catalogue of Federal Domestic Assistance
disability, please contact Sujata Vijh at Program Nos. 93.853, Clinical Research DEPARTMENT OF HEALTH AND
least 7 days in advance of the meeting. Related to Neurological Disorders; 93.854, HUMAN SERVICES
FDA is committed to the orderly Biological Basis Research in the
conduct of its advisory committee Neurosciences, National Institutes of Health, National Institutes of Health
HHS)
meetings. Please visit our Web site at
http://www.fda.gov/ Dated: December 31, 2015. National Institute of Mental Health;
AdvisoryCommittees/ Melanie J. Gray, Notice of Closed Meetings
AboutAdvisoryCommittees/ Program Analyst, Office of Federal Advisory
Pursuant to section 10(d) of the
ucm111462.htm for procedures on Committee Policy.
Federal Advisory Committee Act, as
public conduct during advisory [FR Doc. 2015–33256 Filed 1–5–16; 8:45 am]
amended (5 U.S.C. App.), notice is
committee meetings. BILLING CODE 4140–01–P
hereby given of the following meetings.
Notice of this meeting is given under
the Federal Advisory Committee Act (5 The meetings will be closed to the
U.S.C. app. 2). DEPARTMENT OF HEALTH AND public in accordance with the
HUMAN SERVICES provisions set forth in sections
Dated: December 31, 2015. 552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
Leslie Kux, as amended. The grant applications and
National Institutes of Health
Associate Commissioner for Policy. the discussions could disclose
[FR Doc. 2015–33263 Filed 1–5–16; 8:45 am] National Institute on Drug Abuse confidential trade secrets or commercial
BILLING CODE 4164–01–P Notice of Closed Meeting property such as patentable material,
and personal information concerning
Pursuant to section 10(d) of the individuals associated with the grant
DEPARTMENT OF HEALTH AND Federal Advisory Committee Act, as applications, the disclosure of which
HUMAN SERVICES amended (5 U.S.C. App), notice is would constitute a clearly unwarranted
hereby given of the following meeting. invasion of personal privacy.
National Institutes of Health The meeting will be closed to the
Name of Committee: National Institute of
public in accordance with the Mental Health Special Emphasis Panel,
National Institute of Neurological provisions set forth in sections
Disorders and Stroke; Notice of Closed Confirmatory Efficacy Clinical Trials of Non-
552b(c)(4) and 552b(c)(6), title 5 U.S.C., Pharmacological Interventions for Mental
Meetings as amended. The contract proposals and Disorders.
Pursuant to section 10(d) of the the discussions could disclose Date: January 21, 2016.
Federal Advisory Committee Act, as confidential trade secrets or commercial Time: 12:30 p.m. to 5:00 p.m.
amended (5 U.S.C. App.), notice is property such as patentable material, Agenda: To review and evaluate grant
and personal information concerning applications.
hereby given of the following meetings.
individuals associated with the contract Place: National Institutes of Health,
The meetings will be closed to the
Neuroscience Center, 6001 Executive
public in accordance with the proposals, the disclosure of which Boulevard, Rockville, MD 20852, (Telephone
provisions set forth in sections would constitute a clearly unwarranted Conference Call).
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., invasion of personal privacy. Contact Person: Marcy Ellen Burstein,
as amended. The grant applications and Name of Committee: National Institute on Ph.D., Scientific Review Officer, Division of
the discussions could disclose Drug Abuse Special Emphasis Panel; Extramural Activities, National Institute of
confidential trade secrets or commercial Development of Primer and Reference Tool to Mental Health, NIH, Neuroscience Center,
property such as patentable material, Assess Neonatal Abstinence Syndrome 6001 Executive Blvd., Room 6143, MSC 9606,
and personal information concerning (1210). Bethesda, MD 20892–9606, 301–443–9699,
mstockstill on DSK4VPTVN1PROD with NOTICES

Date: January 15, 2016. bursteinme@mail.nih.gov.
individuals associated with the grant
applications, the disclosure of which Time: 11:00 a.m. to 2:30 p.m. Name of Committee: National Institute of
Agenda: To review and evaluate contract Mental Health Special Emphasis Panel,
would constitute a clearly unwarranted
proposals. Interventions.
invasion of personal privacy. Place: National Institutes of Health, Date: January 28, 2016.
Name of Committee: National Institute of Neuroscience Center, 6001 Executive Time: 2:00 p.m. to 3:00 p.m.
Neurological Disorders and Stroke Special Boulevard, Rockville, MD 20852, (Telephone Agenda: To review and evaluate grant
Emphasis Panel; X01’s BRAC Review. Conference Call). applications.

VerDate Sep<11>2014 17:32 Jan 05, 2016 Jkt 238001 PO 00000 Frm 00034 Fmt 4703 Sfmt 4703 E:\FR\FM\06JAN1.SGM 06JAN1

Document Created: 2016-01-06 04:01:58
Document Modified: 2016-01-06 04:01:58

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		January 14, 2016.
FR Citation		81 FR 492

81 FR 492 - National Institute of Neurological Disorders and Stroke; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 81, Issue 3 (January 6, 2016)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health